PT Kimia Farma Tbk (ISX:KAEF) FFO


ISX:KAEF PT Kimia Farma Tbk ISX:KAEF
56 GF Score
Price Rp456.00
GF Value Rp581.98
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Tbk FFO?

FFO (Funds from operations) only applies to REITs.

ISX:KAEF
56GF Score
PT Kimia Farma Tbk ISX:KAEF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued. The current stock price of Rp456.00 is trading 21.6% below its estimated GF Value™ of Rp581.98. GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • FFO:
  • GF Value™: Rp581.98 vs. price of Rp456.00 (21.6% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Kimia Farma Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
56GF Score

Get the complete analysis for ISX:KAEF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp456.00
Price
Rp581.98
GF Value